SCWorx (WORX) Research & Development (2019)

SCWorx's (WORX) quarterly Research & Development came in at $198450.0 in Q3 2019, down 58.48% quarter-over-quarter from $477950.0 in Q2 2019.

SCWorx (WORX) Research & Development (2019) Analysis & Trends

SCWorx has disclosed Research & Development across 1 years of filings, most recently posting $198450.0 for Q3 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 208.32 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn -
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 67.77 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 30.34 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 56.85 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 39.11 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 18.37 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 21.52 Mn
10 SCWorx - - 374,109.00 -

Historic Data

Download Data
DateValue
Sep 30, 2019 198,450.00
Jun 30, 2019 477,950.00
Mar 31, 2019 182,339.00